Information between 15th November 2021 - 11th August 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Speeches |
---|
Lord Prior of Brampton speeches from: Health and Care Bill
Lord Prior of Brampton contributed 1 speech (782 words) 2nd reading Tuesday 7th December 2021 - Lords Chamber Department of Health and Social Care |
Parliamentary Debates |
---|
Health and Care Bill
67 speeches (22,508 words) Lords Hansard - Part 2 Thursday 13th January 2022 - Lords Chamber Department of Health and Social Care Mentions: 1: Baroness Hayman (CB - Life peer) I am grateful to him, the noble Lord, Lord Prior of Brampton, and the noble Baroness, Lady Young of Old - Link to Speech 2: Lord Stevens of Birmingham (CB - Life peer) inhalers, that the NHS uses, which it procures from 80,000-plus suppliers.I am grateful to the noble Lord, Lord - Link to Speech |
Health and Care Bill
153 speeches (62,469 words) 2nd reading Tuesday 7th December 2021 - Lords Chamber Department of Health and Social Care Mentions: 1: Lord Naseby (CON - Life peer) The crunch, as I said in my supplementary question to my noble friend Lord Prior of Brampton, the then - Link to Speech |
Select Committee Documents |
---|
Tuesday 17th January 2023
Report - Twelfth Report - Documents considered by the Committee on 11 January 2023 European Scrutiny Committee Found: standards” for vehicles, as well as exchange of information (for example on safety 62 Letter from Lord |
Wednesday 19th January 2022
Inquiry Publications - Tenth Report - Pre-appointment hearing for the position of Chair of NHS England Health and Social Care Committee Found: Secretary of State for Health and Social Care wrote to inform us that the current Chair of NHS England, Lord |
Written Answers | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antidepressants
Asked by: Lord Alton of Liverpool (Crossbench - Life peer) Monday 5th February 2024 Question to the Department of Health and Social Care: To ask His Majesty's Government, further to the Written Answer by Lord Prior of Brampton on 23 July 2015 (HL1632), how many prescriptions for antidepressants have been issued in each year since 2014; what was the annual cost to the National Health Service of those prescriptions; and what guidance is given to doctors and patients about the use of antidepressants, their subsequent withdrawal and potential long-term effects. Answered by Lord Markham The following table shows the latest data available on the number of prescriptions for antidepressants issued between 2014 and 2023, and the associated net ingredient cost:
The requirement to provide a patient information leaflet with licensed medicines in the United Kingdom is set out in Regulation 267 of the Human Medicines Regulations 2012. As set out in Schedule 27 of these regulations, the information that must be presented in the leaflet includes special warnings relevant to the safe use of the medicine, and instructions for proper use, including the risk of withdrawal effects and description of all side effects, both long and short term. The leaflet must reflect in lay language, the agreed Summary of Product Characteristics for a medicine, which would include information on risk of addiction, withdrawal and the long-term consequences of taking a medicine. The National Institute for Health and Care Excellence also set outs guidelines for the management and treatment of depression in adults. |
|||||||||||||||||||||||||||||||||
Human Fertilisation and Embryology Authority
Asked by: Lord Alton of Liverpool (Crossbench - Life peer) Thursday 29th June 2023 Question to the Department of Health and Social Care: To ask His Majesty's Government, further to the Written Answer by Lord Prior of Brampton on 11 May 2016 (HL7950), and the Written Answer by Lord Markham on 6 June (HL7725), whether any research applications submitted to the Human Fertilisation and Embryology Authority (HFEA) since March 2011 have been rejected by the HFEA Licence Committee; whether any requests have been received by the HFEA to perform spindle-chromosomal complex transfer; and how many centres in the UK have been granted permission to perform pronuclear transfer in order to facilitate independent scientific validation. Answered by Lord Markham The Human Fertilisation and Embryology Authority (HFEA) has advised that no research applications have been rejected by the HFEA Licence Committee since March 2011. No requests have been received by the HFEA to perform spindle-chromosomal complex transfer. One centre in the UK has been granted permission to perform pronuclear transfer which is the Newcastle Centre For Life. |
Non-Departmental Publications - Transparency |
---|
May. 31 2022
Independent Adviser on Ministers' Interests Source Page: List of ministers' interests Document: List of ministers' interests - December 2016 (PDF) Transparency Found: Lord Prior of Brampton, Parliamentary Under Secretary of State !2. |
May. 31 2022
Independent Adviser on Ministers' Interests Source Page: List of ministers' interests Document: List of ministers' interests - July 2016 (PDF) Transparency Found: Lord Prior of Brampton, Parliamentary Under Secretary of State !2. |
May. 31 2022
Independent Adviser on Ministers' Interests Source Page: List of ministers' interests Document: List of ministers' interests - December 2015 (PDF) Transparency Found: Parliamentary Under - Secretary of State See entry under the Department Business, Innovation and Skills Lord |